$46.19
0.81% yesterday
NYSE, Nov 22, 10:10 pm CET
ISIN
BMG3922B1072
Symbol
G

Genpact Limited Stock price

$46.19
+7.98 20.88% 1M
+11.91 34.74% 6M
+11.48 33.07% YTD
+12.73 38.05% 1Y
-3.91 7.80% 3Y
+6.47 16.29% 5Y
+28.34 158.77% 10Y
NYSE, Closing price Fri, Nov 22 2024
+0.37 0.81%
ISIN
BMG3922B1072
Symbol
G
Sector
Industry

Key metrics

Market capitalization $8.15b
Enterprise Value $8.98b
P/E (TTM) P/E ratio 12.67
EV/FCF (TTM) EV/FCF 17.17
EV/Sales (TTM) EV/Sales 1.93
P/S ratio (TTM) P/S ratio 1.75
P/B ratio (TTM) P/B ratio 3.40
Dividend yield 1.32%
Last dividend (FY24) $0.61
Revenue growth (TTM) Revenue growth 5.24%
Revenue (TTM) Revenue $4.66b
EBIT (operating result TTM) EBIT $657.99m
Free Cash Flow (TTM) Free Cash Flow $522.94m
Cash position $1.02b
EPS (TTM) EPS $3.64
P/E forward 16.18
P/S forward 1.72
EV/Sales forward 1.89
Short interest 3.85%
Show more

Is Genpact Limited a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Genpact Limited Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Genpact Limited forecast:

3x Buy
23%
9x Hold
69%
1x Sell
8%

Analyst Opinions

13 Analysts have issued a Genpact Limited forecast:

Buy
23%
Hold
69%
Sell
8%

Financial data from Genpact Limited

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
4,663 4,663
5% 5%
100%
- Direct Costs 3,048 3,048
5% 5%
65%
1,615 1,615
6% 6%
35%
- Selling and Administrative Expenses 870 870
7% 7%
19%
- Research and Development Expense - -
-
-
745 745
6% 6%
16%
- Depreciation and Amortization 87 87
9% 9%
2%
EBIT (Operating Income) EBIT 658 658
9% 9%
14%
Net Profit 663 663
54% 54%
14%

In millions USD.

Don't miss a Thing! We will send you all news about Genpact Limited directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Genpact Limited Stock News

Neutral
PRNewsWire
2 days ago
Renewed multi-year partnership to support Ferring Pharmaceuticals' operations in response to rapid business growth NEW YORK , Nov. 21, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, today announced the extension of its partnership with Ferring Pharmaceuticals, a research-driven biopharmaceutical company that h...
Neutral
PRNewsWire
3 days ago
Fourth consecutive year of recognition highlights Genpact's expertise in sourcing and procurement, strong partner ecosystem, and advanced technology capabilities driving transformation for clients worldwide NEW YORK , Nov. 20, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, today announced that it has been name...
Neutral
PRNewsWire
5 days ago
Recognition is a testament to Genpact's commitment to positive employee experience and engagement, and its culture of learning and innovation NEW YORK , Nov. 18, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, today announced its inclusion on the Forbes list of World's Best Employers 2024  for the fourth consec...
More Genpact Limited News

Company Profile

Genpact Ltd. engages in the business process management, outsourcing, shared services and information outsourcing. The company operates through the following segments: Banking, Capital Markets and Insurance or BCMI, Consumer Goods, Retail, Life Sciences and Healthcare or CGRLH and High Tech, Manufacturing and Services or HMS. The Segment Banking, Capital Markets and Insurance provides operations services for clients in the insurance industry vertical - such as property and casualty insurers, life and annuities insurers, reinsurance providers and insurance brokerage firms - include underwriting, claims management, regulatory reporting, risk and catastrophe modelling, and customer segmentation and loyalty. The Segment Consumer Goods, Retail, Life Sciences and Healthcare provides operations services to supply chain management, order management, trade promotion optimization, and supplier risk management. The Segment and High Tech, Manufacturing and Services provides operations services to these clients include industry-specific solutions for the Industrial Internet of Things (IIoT), order and supply chain management, digital content management and risk management. The company was founded in 1997 by Pramod Bhasin and is headquartered in Hamilton, Bermuda.

Head office Bermuda
CEO Balkrishan Kalra
Employees 129,100
Founded 1997
Website www.genpact.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today